These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33534880)

  • 21. Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
    Kernéis S; Lucet JC; Santoro A; Meschiari M
    J Antimicrob Chemother; 2021 Jan; 76(Suppl 1):i19-i26. PubMed ID: 33534878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal dissemination of carbapenemase-producing Klebsiella pneumoniae: Two distinct sub-lineages of Sequence Type 11 carrying bla
    Lu MC; Tang HL; Chiou CS; Wang YC; Chiang MK; Lai YC
    Int J Antimicrob Agents; 2018 Nov; 52(5):658-662. PubMed ID: 29753130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
    De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M
    Future Microbiol; 2015; 10(2):283-94. PubMed ID: 25689539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
    Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
    Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in different facilities in Southern Brazil.
    Arend LN; Toledo P; Pilonetto M; Tuon FF
    Am J Infect Control; 2015 Feb; 43(2):137-40. PubMed ID: 25541337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
    J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011.
    Giani T; Pini B; Arena F; Conte V; Bracco S; Migliavacca R; ; Pantosti A; Pagani L; Luzzaro F; Rossolini GM
    Euro Surveill; 2013 May; 18(22):. PubMed ID: 23787077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak.
    Reeme AE; Bowler SL; Buchan BW; Graham MB; Behrens E; Singh S; Hong JC; Arvan J; Hyke JW; Palen L; Savage S; Seliger H; Huerta S; Ledeboer NA; Kotay S; Mathers AJ; Cooper VS; Mustapha MM; Mettus RT; Doi Y; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):767-773. PubMed ID: 31084655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of KPC-producing Klebsiella pneumoniae infections.
    Bassetti M; Giacobbe DR; Giamarellou H; Viscoli C; Daikos GL; Dimopoulos G; De Rosa FG; Giamarellos-Bourboulis EJ; Rossolini GM; Righi E; Karaiskos I; Tumbarello M; Nicolau DP; Viale PL; Poulakou G; ;
    Clin Microbiol Infect; 2018 Feb; 24(2):133-144. PubMed ID: 28893689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization.
    Sbrana F; Malacarne P; Bassetti M; Tascini C; Vegnuti L; Della Siega P; Ripoli A; Ansaldi F; Menichetti F
    Minerva Anestesiol; 2016 Jun; 82(6):635-40. PubMed ID: 26745619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management.
    Cano A; Gutiérrez-Gutiérrez B; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Causse M; Castón JJ; Guzman-Puche J; Torre-Giménez J; Kindelán L; Martínez-Martinez L; Rodriguez-Baño J; Torre-Cisneros J
    Clin Infect Dis; 2018 Apr; 66(8):1204-1210. PubMed ID: 29126110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
    Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects.
    da Silva RM; Traebert J; Galato D
    Expert Opin Biol Ther; 2012 Jun; 12(6):663-71. PubMed ID: 22506862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit.
    Rossi Gonçalves I; Ferreira ML; Araujo BF; Campos PA; Royer S; Batistão DW; Souza LP; Brito CS; Urzedo JE; Gontijo-Filho PP; Ribas RM
    J Hosp Infect; 2016 Dec; 94(4):322-329. PubMed ID: 27654515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of Bronchial Dehiscence in Lung Transplant Recipients With Carbapenemase-producing Klebsiella.
    Suh JW; Lee JG; Jeong SJ; Park MS; Kim SY; Paik HC
    Ann Thorac Surg; 2020 Jul; 110(1):265-271. PubMed ID: 32151582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study.
    Cronin KM; Poy Lorenzo YS; Olenski ME; Bloch AE; Visvanathan K; Waters MJ; Buising KL
    J Hosp Infect; 2017 Jun; 96(2):111-115. PubMed ID: 28389093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
    Rodriguez-Gómez J; Pérez-Nadales E; Gutiérrez-Gutiérrez B; Machuca I; Martinez-Martinez L; Rivera F; Cano A; Castón JJ; Robles JC; de la Fuente C; Rodríguez-López F; Rodriguez-Baño J; Torre-Cisneros J;
    J Infect; 2019 Sep; 79(3):245-252. PubMed ID: 31276705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
    Gaibani P; Campoli C; Lewis RE; Volpe SL; Scaltriti E; Giannella M; Pongolini S; Berlingeri A; Cristini F; Bartoletti M; Tedeschi S; Ambretti S
    J Antimicrob Chemother; 2018 Jun; 73(6):1525-1529. PubMed ID: 29566151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid discrimination of Klebsiella pneumoniae carbapenemase 2-producing and non-producing Klebsiella pneumoniae strains using near-infrared spectroscopy (NIRS) and multivariate analysis.
    Marques AS; Moraes EP; Júnior MAA; Moura AD; Neto VFA; Neto RM; Lima KMG
    Talanta; 2015 Mar; 134():126-131. PubMed ID: 25618648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.